*By Carlo Versano*
Cannabis stocks continued their run Monday on renewed speculation that more big-name companies will add pot to their recreation portfolios.
The latest deal ー Canada's Nova Scotia Liquor inking an initial purchase order with pharmaceutical company Tilray ー sent shares of the latter up as much as 30 percent the day before its first earnings report as a public company. The stocks of Cronos and Canopy Growth, which earlier this month earned an investment from Corona-maker [Constellation Brands](https://cheddar.com/videos/corona-brewer-adds-cannabis-to-its-booze-business-in-4-billion-deal), rose too.
Sam Masucci, CEO and co-founder of ETF Managers Group, is trying to give investors a chance to capitalize on such gains.
He joined Cheddar Monday after ringing the opening bell at the NYSE to detail the ETFMG Alternative Harvest ETF, which launched in 2017. The fund tracks nearly 40 foreign and domestic companies that Masucci said may benefit from the production and sale of cannabis, both medicinal and recreational.
The ETF includes companies as varied as Scotts Miracle-Gro (which is developing hydroponics), Canopy Growth, and tobacco giant Phillip Morris.
Companies in Canada, where marijuana will be legalized for recreational sale in October, make up 40 percent of the basket of stocks, with 20 percent coming from the U.S.
While marijuana remains a Schedule I drug at the federal level in this U.S., legalization has gained serious momentum on a state basis.
Masucci said this fund is intended to capture some of that growing bipartisan acceptance and make a bet that medicinal marijuana will be legalized nationally.
"I think the federal government is starting to come around," he said.
A [market report](https://www.prnewswire.com/news-releases/data-shows-medical-cannabis-could-reach-usd-19-billion-in-sales-by-2027-807442325.html) released Monday predicts medicinal marijuana sales will hit $19 billion domestically within the next decade, with worldwide legal spending on cannabis reaching $57 billion.
That's the kind of upside exposure Masucci said he wanted to deliver to investors with the creation of the first "pure play" cannabis ETF.
For full interview [click here](https://cheddar.com/videos/legal-pot-business-booming).
Wealthfront’s CFO Alan Iberman talks the $2.05B IPO and the major moment for robo banking as the company bets on AI, automation, and “self-driving money."
A rare magnum of Dom Pérignon Vintage 1961 champagne that was specially produced for the 1981 wedding of Prince Charles and Lady Diana has failed to sell during an auction. Danish auction house Bruun Rasmussen handled the bidding Thursday. The auction's house website lists the bottle as not sold. It was expected to fetch up to around $93,000. It is one of 12 bottles made to celebrate the royal wedding. Little was revealed about the seller. The auction house says the bids did not receive the desired minimum price.
The New York Times and President Donald Trump are fighting again. The news outlet said Wednesday it won't be deterred by Trump's “false and inflammatory language” from writing about the 79-year-old president's health. The Times has done a handful of stories on that topic recently, including an opinion column that said Trump is “starting to give President Joe Biden vibes.” In a Truth Social post, Trump said it might be treasonous for outlets like the Times to do “FAKE” reports about his health and "we should do something about it.” The Republican president already has a pending lawsuit against the newspaper for its past reports on his finances.
OpenAI has appointed Slack CEO Denise Dresser as its first chief of revenue. Dresser will oversee global revenue strategy and help businesses integrate AI into daily operations. OpenAI CEO Sam Altman recently emphasized improving ChatGPT, which now has over 800 million weekly users. Despite its success, OpenAI faces competition from companies like Google and concerns about profitability. The company earns money from premium ChatGPT subscriptions but hasn't ventured into advertising. Altman had recently announced delays in developing new products like AI agents and a personal assistant.
President Donald Trump says he will allow Nvidia to sell its H200 computer chip used in the development of artificial intelligence to “approved customers” in China. Trump said Monday on his social media site that he had informed China’s leader Xi Jinping and “President Xi responded positively!” There had been concerns about allowing advanced computer chips into China as it could help them to compete against the U.S. in building out AI capabilities. But there has also been a desire to develop the AI ecosystem with American companies such as chipmaker Nvidia.
